Concourse Financial Group Securities’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6735 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7319 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7316 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7325 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7324 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7256 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7087 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6920 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6671 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6685 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6509 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6449 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6326 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6270 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6080 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5873 |
|